Meeting
2016 Genitourinary Cancers Symposium
Characterization of mutational load in patients with advanced urothelial cancer.
Authors
Sumanta K. Pal
City of Hope, Duarte, CA
Sumanta K. Pal , Siraj Mahamed Ali , Riley Ennis , Julia Andrea Elvin , JoAnn Vergilio , James Suh , Roman Yelensky , Jeffrey S. Ross , Vincent A. Miller , Monika Joshi , Toni K. Choueiri , Philip J. Stephens , Garrett Michael Frampton
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Prostate Cancer; Urothelial Carcinoma; Penile, Urethral, and Testicular Cancers
Track
Urothelial Carcinoma,Prostate Cancer,Penile, Urethral, and Testicular Cancers
Sub Track
Urothelial Carcinoma
Citation
J Clin Oncol 34, 2016 (suppl 2S; abstr 460)
DOI
10.1200/jco.2016.34.2_suppl.460
Abstract #
460
Poster Bd #
K9
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
CDH1-mutated clinically advanced urothelial bladder cancer (UBC): A genomic landscape and real-world clinical outcome study (RWCOS).
First Author: Kyle M Rose
Poster
2023 ASCO Genitourinary Cancers Symposium
Association of biomarkers and outcomes in patients (pts) with metastatic urothelial carcinoma (mUC) treated with immune checkpoint inhibitors (ICIs).
First Author: Kevin R Reyes
Poster
2023 ASCO Genitourinary Cancers Symposium
Biomarkers of response to enfortumab vedotin (EV) in patients (pts) with advanced urothelial carcinoma (aUC): Analysis of the UNITE study.
First Author: Tanya Jindal
Poster
2023 ASCO Genitourinary Cancers Symposium
CDH1-mutated clinically advanced urothelial bladder cancer (UBC): A genomic landscape and real-world clinical outcome study (RWCOS).
First Author: Andrea Necchi